ArticleFrontiers in immunology2025

Follow-up of humoral and cellular immune responses after the third SARS-CoV-2 vaccine dose in multiple myeloma patients.

Vincenzo Raimondi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.